A retrospective cohort study of melanoma prevalence stratified by body site in a Regional Australian Population 1994‐2017: Site‐specific protective mechanisms-Reference-Cited by-同舟云学术

A retrospective cohort study of melanoma prevalence stratified by body site in a Regional Australian Population 1994‐2017: Site‐specific protective mechanisms

Published:2018-11-22 Issue:3 Volume:35 Page:135-140
ISSN:0905-4383
Container-title:Photodermatology, Photoimmunology & Photomedicine
language:en
Short-container-title:Photodermatol Photoimmunol Photomed

Author:

Slape Dana¹,Tang Johnson²,Lawless Ruth¹,McCrossin Ian¹²,Frew John W.¹²³^ORCID

Affiliation:

1. Liverpool HospitalDepartment of Dermatology Liverpool New South Wales Australia

2. University of New South Wales Randwick New South Wales Australia

3. Ingham Institute of Applied Medical ResearchUniversity of New South Wales Randwick New South Wales Australia

Publisher

Wiley

Subject

Dermatology,Radiology Nuclear Medicine and imaging,Immunology,General Medicine,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/phpp.12436

Reference24 articles.

1. The global burden of melanoma: results from the Global Burden of Disease Study 2015

2. Remoteness of residence and survival from cancer in New South Wales

3. Changes in the site distribution of common melanoma subtypes in Queensland, Australia over time: implications for public health campaigns

4. A Landscape of Driver Mutations in Melanoma

5. The association of indoor tanning and melanoma in adults: Systematic review and meta-analysis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An updated algorithm integrated with patient data for the differentiation of atypical nevi from early melanomas: the idScore 2021;Dermatology Practical & Conceptual;2022-07-28

2. Possibilities of early optical diagnosis of skin melanoma based on three-day screening in a large industrial center of the Russian Federation;Klinicheskaya dermatologiya i venerologiya;2021

3. Differences in Risk Factors for Melanoma in Young and Middle-aged Higher-risk Patients;In Vivo;2020

4. Improved Survival with Immunotherapy but Lack of Synergistic Effect with Radiation for Stage IV Melanoma of the Head and Neck;The American Surgeon;2019-10